{"id":8733,"date":"2012-01-26T22:42:57","date_gmt":"2012-01-27T06:42:57","guid":{"rendered":"http:\/\/mattcastille.com\/me\/?p=8733"},"modified":"2012-01-26T22:43:44","modified_gmt":"2012-01-27T06:43:44","slug":"company-developing-drug-from-raw-marijuana-for-u-s-usatoday-com","status":"publish","type":"post","link":"http:\/\/mattcastille.com\/me\/2012\/01\/company-developing-drug-from-raw-marijuana-for-u-s-usatoday-com\/","title":{"rendered":"Company developing drug from raw marijuana for U.S. &#8211; USATODAY.com"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.mattcastille.com\/me\/wp-content\/upload\/2012\/01\/images.jpg\" alt=\"Images\" title=\"images.jpg\" border=\"0\" width=\"272\" height=\"185\" \/><\/p>\n<p><a rel=\"nofollow\" href=\"http:\/\/www.usatoday.com\/USCP\/PNI\/NEWS\/2012-01-23-PNI0123wir-a3filler_ST_U.htm\" >Company developing drug from raw marijuana for U.S. &#8211; USATODAY.com<\/a>: &#8220;A British company, GW Pharma, is in advanced clinical trials for the world&#8217;s first pharmaceutical developed from raw marijuana instead of synthetic equivalents &#8212; a mouth spray it hopes to market in the U.S. as a treatment for cancer pain. And it hopes to see FDA approval by the end of 2013. &#8220;<\/p>\n<p>(Via <a href=\"\"><\/a>.)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Company developing drug from raw marijuana for U.S. &#8211; USATODAY.com: &#8220;A British company, GW Pharma, is in advanced clinical trials for the world&#8217;s first pharmaceutical developed from raw marijuana instead of synthetic equivalents &#8212; a mouth spray it hopes to market in the U.S. as a treatment for cancer pain. And it hopes to see &hellip; <a href=\"http:\/\/mattcastille.com\/me\/2012\/01\/company-developing-drug-from-raw-marijuana-for-u-s-usatoday-com\/\"  class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Company developing drug from raw marijuana for U.S. &#8211; USATODAY.com<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[4],"tags":[],"class_list":["post-8733","post","type-post","status-publish","format-standard","hentry","category-other"],"jetpack_publicize_connections":[],"aioseo_notices":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p4RRl-2gR","_links":{"self":[{"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/posts\/8733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/comments?post=8733"}],"version-history":[{"count":2,"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/posts\/8733\/revisions"}],"predecessor-version":[{"id":8735,"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/posts\/8733\/revisions\/8735"}],"wp:attachment":[{"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/media?parent=8733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/categories?post=8733"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/mattcastille.com\/me\/wp-json\/wp\/v2\/tags?post=8733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}